VIENNA, Va.--(BUSINESS WIRE)--CEL-SCI Corporation (NYSE American: CVM) today reported positive results from a bias analysis conducted for its concluded Phase 3 study of Multikine (Leukocyte ...
COULD ACTUALLY BE MUCH MORE ACCURATE. A MARY SALADNA IS IN THE NEWSROOM AND MARY THE RESULTS AREN’T GOOD. NO, THEY’RE NOT, BUT THE RESULTS ARE MORE REALISTIC AND MORE PROOF THAT BODY COMPOSITION ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback